Purdue Pharma & Sackler Family Hit with $7.4B Opioid Crisis Settlement

New York – In a historic move against the pharmaceutical industry’s role in the opioid crisis, New York Attorney General Letitia James announced a $7.4 billion settlement with Purdue Pharma and the Sackler family. This landmark deal, the largest to date with individuals responsible for fueling the crisis, aims to fund addiction treatment and prevention programs nationwide.

Under the leadership of the Sacklers, Purdue Pharma invented, manufactured, and aggressively marketed opioids for decades, contributing significantly to the wave of addiction and overdose deaths. The settlement ends their control over Purdue and bars them from selling opioids in the U.S.

Attorney General James stated, ‘The Sackler family pursued profit at the expense of vulnerable patients, playing a critical role in starting and fueling the opioid epidemic. This massive influx of funds will bring resources to communities in need so we can heal.’

New York alone will receive up to $250 million from the settlement to support treatment and recovery programs. The $7.4 billion will be distributed over 15 years, with significant payments in the first three years.

The settlement also ends Purdue Pharma’s ability to lobby or market opioids and sets up a board of trustees to determine the company’s future. This victory marks another step in New York’s battle against the devastating impact of the opioid crisis.

RELATED: Purdue Pharma Bankruptcy Plan Approved by NY AG

RELATED: Letitia James Secures Approval of Purdue Bankruptcy Plan